Vaccinex, Inc.

NASDAQ:VCNX

3.29 (USD) • At close November 5, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 0.2320.104-0.3860.0200.550.050.05000.850.0500.850.050.050000.4040.0250.0940.1940.1980.1260.2060.09000
Kosten van de omzet 0.0250.0270.0270.0310.030.0310.04500.0540.0410.0413.6290.0355.5130.0020.0024.5195.4094.4110.0080.0160.1750.3010.2460.2460.240.16000
Brutowinst 0.2070.077-0.413-0.011-0.030.5190.0050.05-0.054-0.0410.809-3.579-0.035-4.6630.0480.048-4.519-5.409-4.4110.3960.009-0.081-0.107-0.048-0.12-0.034-0.07000
Brutowinstmarge 0.8920.741.069-0.5500.9440.11000.952-71.580-5.4860.960.960000.980.36-0.862-0.552-0.242-0.952-0.165-0.778000
Onderzoek- en ontwikkelingskosten 3.8393.3833.3314.3555.053.8123.7413.4293.8432.9663.9543.6294.0645.5134.2497.3344.5575.4094.4116.5437.3047.4127.0735.3145.5124.4545.0284.2923.3923.839
Algemene en administratieve kosten 2.091.7951.6311.4992.0271.7241.6031.4131.5581.6281.5641.4841.6051.5771.841.8721.9431.751.9281.5311.5631.6471.3811.0920.9251.2211.0991.041.2741.07
Verkoop- en marketingkosten -000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.091.7951.6311.4992.0271.7241.6031.4131.5581.6281.5641.4841.6051.5771.841.8721.9431.751.9281.5311.5631.6471.3811.0920.9251.2211.0991.041.2741.07
Overige kosten 0.016-0.001-0.0520.9220.0170.024-0.1750.0340.0190-0.005-0.0010.051-0.002-0.017-0.023-0.0010.010.0130.0360.030.0730.1120.0670-0.014-0.0170-0.007-0.016
Bedrijfskosten 5.9295.1784.9625.8547.0775.5365.1694.8425.4014.5945.5185.1135.6697.096.0898.6316.57.1596.3398.0748.8679.0598.4546.4066.4375.6756.1275.3324.6664.909
Bedrijfsresultaat -5.722-5.074-4.988-5.834-7.077-4.986-5.119-4.792-5.401-4.594-5.518-5.063-5.669-6.24-6.089-8.583-6.5-7.159-6.339-7.678-8.858-9.14-8.561-6.454-6.557-5.709-6.197-5.332-4.666-4.909
Bedrijfsresultaat ratio -24.664-48.78812.922-291.70-9.065-102.38-95.8400-6.492-101.260-7.341-121.78-171.66000-19.005-354.32-97.234-44.129-32.596-52.04-27.714-68.856000
Totaal overige inkomsten en kosten netto 0.0911.1771.6710.9220.0170.0240.0410.0340.018-0.0010.871-0.0010.051-0.002-0.017-0.023-0.0010.010.0130.0360.030.0730.112-0.1010.03-1.8863.940.1570.142-0.536
Inkomen voor belasting -5.631-3.897-3.317-4.912-7.06-4.962-5.078-4.759-5.383-4.595-4.631-5.206-5.969-6.574-6.445-8.754-6.501-7.149-6.326-7.642-8.828-9.067-8.449-6.599-6.608-7.862-2.627-5.536-4.879-5.717
Inkomen voor belasting ratio -24.272-37.4718.593-245.60-9.022-101.56-95.1800-5.448-104.120-7.734-128.9-175.08000-18.916-353.12-96.457-43.552-33.328-52.444-38.165-29.189000
Belastingkosten -5.747-0.0270.038-0.0310.017-0.024-0.0590.035-0.0180.001-0.0160.1410.4020.330.3220.125000.0130.0360.030.0730.1120.1110.0810.2530.3160.3610.3480.256
Nettowinst -5.631-3.897-3.317-4.912-7.06-4.938-5.019-4.759-5.365-4.596-4.631-5.206-5.969-6.574-6.445-8.754-6.501-7.149-6.326-7.642-8.828-9.067-8.449-6.599-6.608-7.862-2.59-5.536-4.879-5.717
Nettowinstmarge -24.272-37.4718.593-245.60-8.978-100.38-95.1800-5.448-104.120-7.734-128.9-175.08000-18.916-353.12-96.457-43.552-33.328-52.444-38.165-28.778000
WPA (Winst Per Aandeel) -3.1-2.94-3.29-15.26-25.2-20.9-23.08-23.42-27.21-25.21-32.41-35.49-43.86-54.75-60.46-91.57-81.8-93.83-89.86-116.63-161.5-165.92-153.69-195.77-172.76-289.69-95.43-203.99-179.78-210.66
Verwaterde WPA -3.1-2.94-3.29-15.26-24.54-20.79-23.08-23.42-26.41-24.9-31.57-35.49-43.86-54.75-60.46-91.57-81.8-93.83-89.86-116.63-161.5-165.92-153.69-195.77-172.76-289.69-95.43-203.99-179.78-210.66
EBITDA -5.697-5.074-4.962-5.834-7.03-4.931-5.033-4.691-5.328-4.553-4.606-5.027-5.582-6.187-6.036-8.531-6.413-7.084-6.258-7.578-8.771-9.007-8.392-6.333-6.501-5.667-6.16-5.278-4.623-4.877
EBITDA ratio -24.556-48.78812.854-291.70-8.965-100.66-93.8200-5.419-100.540-7.279-120.72-170.62000-18.757-350.84-95.819-43.258-31.985-51.595-27.51-68.444000